Photodiagnosis and Photodynamic Therapy
Volume 5, Issue 3 , Pages 217-223 , September 2008

Dosimetric concepts for PDT

References 

  1. Weishaupt KR, Gomer CJ, Dougherty TJ. Identification of singlet oxygen as the cytotoxic agent in photoinactivation of a murine tumor. Cancer Res. 1976;36:2326–2329
  2. Product monograph; Photofrin package insert: Axcan Pharma, Mt. St. Hilaire, Quebec, Canada.
  3. Mang TS. Lasers and light sources for PDT: past present and future. Photodiagn Photodyn Ther. 2004;1:43–48
  4. Fractionation, In: Clinical Radiobiology, eds. Duncan W, Nias AHW. 1977. Churchill Livingstone: Edinburgh, London, New York. ISBN 0443011478.
  5. Star WM, Wilson BC, Patterson MS. Light delivery and optical dosimetry in photodynamic therapy of solid tumors. In:  Henderson BW,  Dougherty TJ editor. Photodynamic therapy: basic principles and clinical applications. Marcel Dekker Inc.; 1992;
  6. Biel MA. Review: photodynamic therapy treatment of early oral and laryngeal tumors. Photochem Photobiol. 2007;83:1063–1068
  7. Mang TS. PDT laser physics and safety. In:  Biel Merrill editors. Photodynamic Therapy of diseases of the head and neck. Plural Publishing; 2008;
  8. Khan SA, Dougherty TJ, Mang TS. An evaluation of photodynamic therapy in the management of cutaneous metastases of breast cancer. Eur J Cancer. 1993;294:1686–1690
  9. Mang TS, McGinnis C, Crean DH, Khan S, Liebow C. Fluorescence detection of tumors: studies on the early diagnosis of microscopic lesions in pre-clinical and clinical studies. J Cell Pharmacol. 1992;3:132–140
  10. Mang TS, Dougherty TJ, Potter WR, Boyle DG, Somer S, Moan J. Photobleaching of Porphyrins used in photodynamic therapy and implications for therapy. Photochem Photobiol. 1987;45:501–506
  11. Moan J, Christiansen T, Jacobsen PB. Porphyrin-sensitized photoinactivation of cells in vitro. In:  Doiron DR,  Gomer CJ editor. Porphyrin localization and treatment of tumors. New York: Alan r. Liss; 1984;p. 419–442
  12. Potter WR, Mang TS, Dougherty TJ. The theory of photodynamic therapy dosimetry: consequences of photodestruction of sensitizer. Photochem Photobiol. 1987;46:97–101
  13. AAPM Report No. 88. Photodynamic Therapy Dosimetry. 2005. Published for the American Association of Physicists in Medicine by Medical Physics Publishing.
  14. Wilson BD, Mang TS, Stoll H, Jones C, Cooper M, Dougherty TJ. Photodynamic therapy for the treatment of Basal Cell carcinoma. Archof Dermatol. 1992;128:15971601
  15. Moseley H. Discussion paper: total effective fluence: a useful concept in photodynamic therapy. Lasers Med Sci. 1996;11:139–143
  16. Fitzpatrick TB. Soleil et peau. J. Med. Esthet. 1975;233–234
  17. Wilson BC, Patterson MS, Lilge L. Review article: implicit and explicit dosimetry in photodynamic therapy: a new paradigm?. Lasers Med Sci. 1997;12:182–199
  18. Pennington DG, Waner M, Knox A. Photodynamic therapy for multiple skin cancers. Plast Reconstr Surg. 1988;82:1067–1071
  19. McCaughan JS, Guy JT, Hicks W, Laufman L, Nims TA, Walker J. Photodynamic therapy for cutaneous and subcutaneous malignant neoplasms. Arch Surg. 1989;124:211–216
  20. Wilson BD, Mang TS, Cooper M, Stoll H. Use of photodynamic therapy for the treatment of extensive basal cell carcinomas. Facial Plast Surg. 1989;6:185–189
  21. Allison RR, Mang TS, Wilson BD. Photodynamic therapy for the treatment of nonmelanomatous cutaneous malignancies. Semin Cutan Med Surg. 1998;17:153–163
  22. Oseroff AR, Bluemenson LR, Wilson BD, et al. A dose ranging study of photodynamic therapy with porfimer sodium (Photofrin) for treatment of basal cell carcinoma. Lasers Surg Med. 2006;38:417–426
  23. Barr H. Photodynamic therapy for high grade dysplasia in Barrett’s Esophagus. Tech Gastrointest Endosc. 2005;7:60–65
  24. Barr H, Stone N, Ding DCD, Kendall C. Current Practice in management of high-grade dysplasia in Barrett’s oesophagus: the real problem. Photodiagn Photodyn Ther. 2008;5:38–41
  25. Panjehpour M, Overholt BF, DeNovo R, Sneed R, Petersen MG. Centering balloon to improve esophageal photodynamic therapy. Lasers Surg Med. 1992;12:631–638
  26. Prout GR, Lin CW, Benson R, et al. Photodynamic therapy with hematoporphyrin derivative in the treatment of superficial transitional cell carcinoma of the bladder. N Engl J Med. 1987;317:1251–1255
  27. Shumaker BP, Lutz MD, Haas GP, Hetzel F. Practical clinical use of laser photodynamic therapy in the treatment of bladder carcinoma in situ. Lasers Med Sci. 1986;1:257–261
  28. Biel MA. Photodynamic therapy and the treatment of head and neck cancers. J Clin Laser Med Surg. 1996;14:239–244

PII: S1572-1000(08)00081-1

doi: 10.1016/j.pdpdt.2008.09.006

Photodiagnosis and Photodynamic Therapy
Volume 5, Issue 3 , Pages 217-223 , September 2008

Article Tools